Schroder Investment Management Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,250
| Closed | -$54K | – | 1419 |
|
|
2021
Q4 | $54K | Buy |
+1,250
| New | +$54K | ﹤0.01% | 1323 |
|
|
2021
Q3 | – | Sell |
-1,250
| Closed | -$79K | – | 1502 |
|
|
2021
Q2 | $79K | Hold |
1,250
| – | – | ﹤0.01% | 1434 |
|
|
2021
Q1 | $116K | Sell |
1,250
-2,615
| -68% | -$243K | ﹤0.01% | 1374 |
|
|
2020
Q4 | $346K | Sell |
3,865
-45,836
| -92% | -$4.1M | ﹤0.01% | 1245 |
|
|
2020
Q3 | $4.98M | Buy |
+49,701
| New | +$4.98M | 0.01% | 724 |
|
|
2019
Q2 | – | Sell |
-9,539
| Closed | -$482K | – | 1205 |
|
|
2019
Q1 | $482K | Sell |
9,539
-147,700
| -94% | -$7.46M | ﹤0.01% | 1005 |
|
|
2018
Q4 | $9.32K | Buy |
+157,239
| New | +$9.32K | 0.02% | 570 |
|
|
2017
Q1 | – | Sell |
-8,863
| Closed | -$291K | – | 1244 |
|
|
2016
Q4 | $291K | Sell |
8,863
-414
| -4% | -$13.6K | ﹤0.01% | 1009 |
|
|
2016
Q3 | $293K | Buy |
+9,277
| New | +$293K | ﹤0.01% | 1014 |
|
|
2015
Q4 | – | Sell |
-1,250
| Closed | -$36K | – | 1192 |
|
|
2015
Q3 | $36K | Hold |
1,250
| – | – | ﹤0.01% | 1104 |
|
|
2015
Q2 | $40K | Buy |
+1,250
| New | +$40K | ﹤0.01% | 1128 |
|